Article
Circulating MicroRNA as Biomarkers of Anthracycline-Induced Cardiotoxicity
27 Feb 2024
Abstract excerpt
Close monitoring for cardiotoxicity during anthracycline chemotherapy is crucial for early diagnosis and therapy guidance. Currently, monitoring relies on cardiac imaging and serial measurement of cardiac biomarkers like cardiac troponin and natriuretic peptides. However, these conventional biomarkers are nonspecific indicators of cardiac damage. Exploring new, more specific biomarkers with a clear link to the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
